1. Home
  2. HALO vs AXTA Comparison

HALO vs AXTA Comparison

Compare HALO & AXTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • AXTA
  • Stock Information
  • Founded
  • HALO 1998
  • AXTA 1910
  • Country
  • HALO United States
  • AXTA United States
  • Employees
  • HALO N/A
  • AXTA N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • AXTA Paints/Coatings
  • Sector
  • HALO Health Care
  • AXTA Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • AXTA Nasdaq
  • Market Cap
  • HALO 7.4B
  • AXTA 8.1B
  • IPO Year
  • HALO N/A
  • AXTA 2014
  • Fundamental
  • Price
  • HALO $61.06
  • AXTA $33.45
  • Analyst Decision
  • HALO Buy
  • AXTA Buy
  • Analyst Count
  • HALO 9
  • AXTA 12
  • Target Price
  • HALO $61.63
  • AXTA $43.58
  • AVG Volume (30 Days)
  • HALO 1.4M
  • AXTA 1.9M
  • Earning Date
  • HALO 05-06-2025
  • AXTA 04-30-2025
  • Dividend Yield
  • HALO N/A
  • AXTA N/A
  • EPS Growth
  • HALO 63.33
  • AXTA 47.33
  • EPS
  • HALO 3.43
  • AXTA 1.78
  • Revenue
  • HALO $1,015,324,000.00
  • AXTA $5,276,000,000.00
  • Revenue This Year
  • HALO $20.06
  • AXTA $3.71
  • Revenue Next Year
  • HALO $23.87
  • AXTA $3.91
  • P/E Ratio
  • HALO $17.78
  • AXTA $18.66
  • Revenue Growth
  • HALO 22.44
  • AXTA 1.77
  • 52 Week Low
  • HALO $37.73
  • AXTA $30.41
  • 52 Week High
  • HALO $65.53
  • AXTA $41.66
  • Technical
  • Relative Strength Index (RSI)
  • HALO 68.07
  • AXTA 34.97
  • Support Level
  • HALO $60.38
  • AXTA $33.36
  • Resistance Level
  • HALO $63.11
  • AXTA $35.96
  • Average True Range (ATR)
  • HALO 1.73
  • AXTA 0.98
  • MACD
  • HALO 0.12
  • AXTA -0.27
  • Stochastic Oscillator
  • HALO 66.99
  • AXTA 7.02

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About AXTA Axalta Coating Systems Ltd.

Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific, and Latin America.

Share on Social Networks: